The French Nuclear Safety and Radiation Protection Authority has issued a favourable opinion on national radioactive waste ...
The American Society of Nephrology’s AI workgroup introduced a clinical framework for responsible AI use at ASN Kidney ...
On the first day of ASN 2025 Kidney Week, Dr Sumeska Thavarajah reports on several clinical trials in kidney disease that were presented, notably including a phase 2 study of rilparencel, a stem cell ...
VERO BEACH, Fla., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical-stage biopharmaceutical company developing Next Generation Cancer (NGC) therapies and ...
Processa to present FSGS treatment study at ASN Kidney Week 2025 ...
🎯 See optimal entry zones for Nasdaq futures - look for “Analyze chart” above graph on Nasdaq futures page Try Now Processa to present FSGS treatment study at ASN Kidney Week 2025 Company News ...
(MENAFN- GlobeNewsWire - Nasdaq) VERO BEACH, Fla., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical-stage biopharmaceutical company developing Next ...
Credit: Getty Images ASN’s Kidney Week 2025 is happening November 5-9, 2025 at the George R. Brown Convention Center in Houston, Texas. ASN’s Kidney Week 2025 promises a robust program: Plenary ...
Conference MDAngle offers personal perspectives from conference attendees, showcasing their anticipation, quick takeaways, and insights into how the presented research will affect their patients. Dr ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. KidneyCure is ASN’s philanthropic foundation that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback